The estimated Net Worth of Caren Deardorf is at least $740 Mille dollars as of 16 September 2021. Caren Deardorf owns over 6,238 units of Crinetics Pharmaceuticals Inc stock worth over $698,284 and over the last 3 years Caren sold CRNX stock worth over $41,982.
Caren has made over 1 trades of the Crinetics Pharmaceuticals Inc stock since 2021, according to the Form 4 filled with the SEC. Most recently Caren sold 6,238 units of CRNX stock worth $41,982 on 16 September 2021.
The largest trade Caren's ever made was selling 6,238 units of Crinetics Pharmaceuticals Inc stock on 16 September 2021 worth over $41,982. On average, Caren trades about 520 units every 0 days since 2021. As of 16 September 2021 Caren still owns at least 13,762 units of Crinetics Pharmaceuticals Inc stock.
You can see the complete history of Caren Deardorf stock trades at the bottom of the page.
Caren's mailing address filed with the SEC is C/O CRINETICS PHARMACEUTICALS, INC., 6055 LUSK BOULEVARD, SAN DIEGO, CA, 92121.
Over the last 6 years, insiders at Crinetics Pharmaceuticals Inc have traded over $52,514,606 worth of Crinetics Pharmaceuticals Inc stock and bought 3,613,259 units worth $62,800,483 . The most active insiders traders include Advisors Llcperceptive Life..., Jack Nielsen e Capital Viii, Llc Vivo Capi.... On average, Crinetics Pharmaceuticals Inc executives and independent directors trade stock every 20 days with the average trade being worth of $3,116,248. The most recent stock trade was executed by Stephen F. Betz on 26 August 2024, trading 3,000 units of CRNX stock currently worth $159,570.
neuropeptide receptor targeted therapeutics for the treatment of endocrine diseases and cancers. we are driven by a passion for drug-hunting and tempered by a post-recession startup culture. our goal is to create new therapeutics that can make a meaningful difference in the lives of our patients.
Crinetics Pharmaceuticals Inc executives and other stock owners filed with the SEC include: